ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,967.84
      -0.22%
      US Tech 100
      21,102.40
      -0.27%
      Dow Jones
      42,206.82
      0.08%
      Brent Oil
      76.125
      0.00%
      Bitcoin
      103,801.76
      0.47%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Arcellx Inc (ACLX) Quote

      Arcellx Inc

      Arcellx Inc (ACLX)

      NASDAQ
      63.00
      -0.82
      (-1.28%)
      Closed June 21 4:00PM
      15 min delayed - Upgrade to Realtime
      63.00
      -0.09
      (-0.14%)
      After Hours: 5:30PM
      15 min delayed - Upgrade to Realtime

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      63.00
      Bid
      58.85
      Ask
      69.37
      Volume
      986,911
      60.92 Day's Range 64.64
      47.8601 52 Week Range 107.3699
      Market Cap
      3.472B
      Previous Close
      63.82
      Open
      64.25
      Last Trade
      8932
      @
      63
      (priorref)
      Last Trade Time
      Financial Volume
      $ 61,779,734
      VWAP
      62.5991
      Average Volume (3m)
      787,824
      Shares Outstanding
      55,106,703
      Dividend Yield
      -
      PE Ratio
      -32.34
      Earnings Per Share (EPS)
      -1.95
      Revenue
      107.94M
      Net Profit
      -107.35M

      About Arcellx Inc

      Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.arcellx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Arcellx Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ACLX. The last closing price for Arcellx was $63.82. Over the last year, Arcellx shares have traded in a share price range of $ 47.8601 to $ 107.3699.

      Arcellx currently has 55,106,703 shares outstanding. The market capitalization of Arcellx is $3.52 billion. Arcellx has a price to earnings ratio (PE ratio) of -32.34.

      Ask ADVFN Intelligence (AI)

      Arcellx (ACLX) Options Flow Summary

      ACLX Options Flow

      Overall Flow

      Bearish

      Net Premium

      -490k

      Calls / Puts

      50.00%

      Buys / Sells

      200.00%

      OTM / ITM

      50.00%

      Sweeps Ratio

      0.00%

      ACLX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 30 2025
      ACLX (-1.28%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 14 2025
      ACLX (-1.28%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 08 2025
      ACLX (-1.28%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 08 2025
      ACLX (-1.28%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.9-2.9275808936864.966.7362.12549962364.22979933CS
      4-0.44-0.69356872635663.4469.078460.66555636764.43044411CS
      12-5.54-8.0828713160268.5469.8447.860178782460.58843655CS
      26-11.16-15.048543689374.168147.860170649064.30279639CS
      529.2317.165705783953.77107.369947.860160564169.79983437CS
      15646.84289.85148514916.16107.369914.8554934249.95867806CS
      26044231.57894736819107.36996.03551173048.47821459CS

      ACLX - Frequently Asked Questions (FAQ)

      What is the current Arcellx share price?
      The current share price of Arcellx is $ 63.00
      How many Arcellx shares are in issue?
      Arcellx has 55,106,703 shares in issue
      What is the market cap of Arcellx?
      The market capitalisation of Arcellx is USD 3.52B
      What is the 1 year trading range for Arcellx share price?
      Arcellx has traded in the range of $ 47.8601 to $ 107.3699 during the past year
      What is the PE ratio of Arcellx?
      The price to earnings ratio of Arcellx is -32.34
      What is the cash to sales ratio of Arcellx?
      The cash to sales ratio of Arcellx is 32.16
      What is the reporting currency for Arcellx?
      Arcellx reports financial results in USD
      What is the latest annual turnover for Arcellx?
      The latest annual turnover of Arcellx is USD 107.94M
      What is the latest annual profit for Arcellx?
      The latest annual profit of Arcellx is USD -107.35M
      What is the registered address of Arcellx?
      The registered address for Arcellx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Arcellx website address?
      The website address for Arcellx is www.arcellx.com
      Which industry sector does Arcellx operate in?
      Arcellx operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NXTTNext Technology Holding Inc
      $ 3.44
      (158.65%)
      		13.84M
      WHLRWheeler Real Estate Investment Trust Inc
      $ 7.15
      (109.06%)
      		52.35M
      CTORCitius Oncology Inc
      $ 2.63
      (69.68%)
      		20.77M
      LUCYInnovative Eyewear Inc
      $ 3.52
      (54.39%)
      		111.21M
      LGCLLucas GC Ltd
      $ 1.0407
      (53.16%)
      		11.17M
      NWGLNature Wood Group Ltd
      $ 1.71
      (-69.63%)
      		3.99M
      ICUSeaStar Medical Holding Corporation
      $ 0.351
      (-64.05%)
      		21.9M
      MBRXMoleculin Biotech Inc
      $ 0.259999
      (-55.40%)
      		16.84M
      RGCRegencell Bioscience Holdings Ltd
      $ 37.50
      (-40.81%)
      		2.22M
      CGTLCreative Global Technology Holdings Ltd
      $ 1.4399
      (-36.57%)
      		6.71M
      HCTIHealthcare Triangle Inc
      $ 0.0297
      (12.08%)
      		583.72M
      DFLIDragonfly Energy Holdings Corporation
      $ 0.245
      (12.39%)
      		334.37M
      GNLNGreenlane Holdings Inc
      $ 0.009
      (-13.04%)
      		262.88M
      NVDANVIDIA Corporation
      $ 143.85
      (-1.12%)
      		242.95M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 12.359
      (-0.09%)
      		193.97M

      ACLX Discussion

      View Posts
      jondoeuk jondoeuk 4 days ago
      Update https://www.oncologypipeline.com/apexonco/eha-2025-arcellx-still-hopes-safety-will-trump-efficacy
      👍️0
      Monksdream Monksdream 8 months ago
      ACLX under $100
      👍️0
      Monksdream Monksdream 9 months ago
      ACLX new 52 week high
      👍️0
      Monksdream Monksdream 11 months ago
      ACLX under $100
      👍️0
      Monksdream Monksdream 1 year ago
      ACLX over $30
      👍️0
      Monksdream Monksdream 1 year ago
      ACLX new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      ACLX new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      ACLX new 52 week high
      👍️0
      bandit007 bandit007 3 years ago
      Going beast mode into next week.
      👍️0
      TheyWantYourShares TheyWantYourShares 3 years ago
      Nice correction coming here. New IPO at 16… company is flush with capital/cash. Moves coming and getting in now will pay off big IMHO.


      Got in on the drop @average: 13.12 … 2 and 3 days ago.


      $ACLX


      GLTA!!



      -TWYS
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Net loss of $44M > no revenues! ( over 9 month period)

      ACLX
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer treatments, looks to raise up to $140.25 million. The company said it is offering 8.25 million shares in the IPO, which is expected to price between $15 and $17 a share. With 33.54 million shares expected to be outstanding after the IPO, the expected pricing could value the company at up to $570.24 million. The stock is expected to list on the Nasdaq under the ticker symbol "ACLX." BofA Securities, SVB Leerink, Barclays and William Blair are the lead underwriters. The company recorded a net loss of $44.30 million on no revenue during the nine months ended Sept. 30, after a loss of $23.00 million on no revenue in the same period a year ago. Arcellx is looking to go public at a time of relative investor disdain for IPOs and biotechs, as the Renaissance IPO ETF IPO, -3.27% has plunged 37.2% over the past three months and the iShares Biotechnology ETF IBB, -1.39% has tumbled 19.8%, while the S&P 500 SPX, +0.31% has slipped 3.8%.
      👍️0

      Your Recent History

      NASDAQ
      ACLX
      Arcellx
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads